ℹ️ Compiled from public regulatory records · Last regulator revision: January 21, 2026🚩 Report this page
Kalmia Latifolia Leaf
Active ingredient
Sold as Joint Tonic R I
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 28
Overview
Kalmia Latifolia Leaf is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 21, 2026 |
USUnited States· FDA
1 product
Uses
** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 183e5794-76a4-45… · revised January 21, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.